Shandong Weigao Medical Polymer Market Cap 2012-2018 | SHWGF

Shandong Weigao Medical Polymer market cap history and chart from 2012 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Shandong Weigao Medical Polymer market cap as of July 13, 2020 is $13.7B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $13.702B $0.931B
Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of single-use medical devices. Single use products offered by the Company includes syringes, blood bags and blood component segregator consumables, blood sampling products, dental and anesthetic consumables, and prefilled syringes for pre-pack medication and etc. It also offers orthopedic materials and instruments like trauma products of steel plates and screws, spinal implants, and artificial joints; blood purification consumables, such as puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers, PVC granules, and related consumables, as well as immunity adsorption products for the treatment of immune system diseases; and cardiovascular stents, including drug eluting stents and balloons. Shandong Weigao Group Medical Polymer Company is based in Weihai, the People's Republic of China.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $164.573B 28.54
Medtronic (MDT) Ireland $121.803B 19.78
Stryker (SYK) United States $66.678B 21.64
Boston Scientific (BSX) United States $48.529B 22.82
Baxter (BAX) United States $43.229B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.790B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.034B 0.00
Terumo (TRUMY) Japan $28.019B 35.82
ResMed (RMD) United States $27.789B 43.86
Zimmer Biomet Holdings (ZBH) United States $24.651B 15.51
Sunny Optical Technology (SNPTF) China $19.798B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.859B 0.00
Bio-Rad Laboratories (BIO) United States $14.161B 64.46
Insulet (PODD) United States $13.110B 1298.88
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $10.359B 81.40
GN STORE NORD (GNNDY) Denmark $7.527B 38.37
Perrigo (PRGO) Ireland $7.520B 13.46
Hill-Rom Holdings (HRC) United States $7.384B 20.82
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $6.112B 0.00
Haemonetics (HAE) United States $4.436B 26.64
Neogen (NEOG) United States $4.094B 69.35
GW Pharmaceuticals (GWPH) United Kingdom $3.971B 0.00
ICU Medical (ICUI) United States $3.820B 27.86
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.796B 0.00
Agios Pharmaceuticals (AGIO) United States $3.644B 0.00
Abcam (ABCZY) $3.447B 0.00
Envista Holdings (NVST) United States $3.215B 0.00
NuVasive (NUVA) United States $2.805B 22.52
TG Therapeutics (TGTX) United States $2.618B 0.00
National Vision Holdings (EYE) United States $2.314B 40.03
AtriCure (ATRC) United States $1.753B 0.00
MacroGenics (MGNX) United States $1.500B 0.00
Aurora Cannabis (ACB) Canada $1.361B 0.00
NanoString Technologies (NSTG) United States $1.319B 0.00
Aphria (APHA) Canada $1.238B 0.00
Cerus (CERS) United States $1.120B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.112B 0.00
Cardiovascular Systems (CSII) United States $1.032B 0.00
Meridian Bioscience (VIVO) United States $1.025B 38.60
Phibro Animal Health (PAHC) United States $1.015B 20.24
PetIQ (PETQ) United States $0.992B 28.64
Vapotherm (VAPO) United States $0.983B 0.00
Zynex (ZYXI) United States $0.949B 95.27
OraSure Technologies (OSUR) United States $0.833B 167.81
InMode (INMD) Israel $0.826B 17.45
Quanterix (QTRX) United States $0.772B 0.00
Omeros (OMER) United States $0.742B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.663B 47.50
BioLife Solutions (BLFS) United States $0.620B 176.54
VAREX IMAGING (VREX) United States $0.586B 14.54
Lantheus Holdings (LNTH) United States $0.573B 11.54
Surmodics (SRDX) United States $0.570B 68.62
LeMaitre Vascular (LMAT) United States $0.519B 29.58
Owens & Minor (OMI) United States $0.459B 12.13
Viemed Healthcare (VMD) United States $0.408B 36.17
Cytosorbents (CTSO) United States $0.367B 0.00
HEXO (HEXO) $0.334B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.330B 0.00
Utah Medical Products (UTMD) United States $0.302B 21.93
Organigram Holdings (OGI) Canada $0.269B 0.00
Female Health (VERU) United States $0.208B 0.00
Chimerix (CMRX) United States $0.190B 0.00
Surface Oncology (SURF) United States $0.163B 0.00
Bovie Medical (APYX) United States $0.163B 0.00
Fonar (FONR) United States $0.136B 12.09
Exagen (XGN) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.125B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Wound Management Technologies (SMTI) United States $0.117B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.115B 0.00
Evolus (EOLS) United States $0.108B 0.00
MTech Acquisition (KERN) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.086B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.078B 0.00
Nephros (NEPH) United States $0.066B 0.00
United-Guardian (UG) United States $0.066B 15.32
Trinity Biotech (TRIB) Ireland $0.064B 0.00
Capricor Therapeutics (CAPR) United States $0.062B 0.00
Brainsway (BWAY) Israel $0.060B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.033B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00